These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3526054)

  • 21. [Treatment and prevention of infections with cefoxitin sodium in patients with biliary tract infections and obstructive jaundice].
    Fuji T; Harima K; Ariyama S; Maetani N; Nagatomi Y; Kawashima M; Aibe T; Amano H; Asagami F; Goto T; Kawamura S; Takemoto T
    Jpn J Antibiot; 1982 Aug; 35(8):1987-92. PubMed ID: 7154246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute and chronic biliary tract infections. Studies of the therapeutic effect of a new broad-spectrum cephalosporin].
    Eisenburg J
    Fortschr Med; 1983 Aug; 101(31-32):1407-12. PubMed ID: 6618404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High risk of bacterobilia in advanced experimental chronic fasciolosis.
    Valero MA; Navarro M; Garcia-Bodelon MA; Marcilla A; Morales M; Hernandez JL; Mengual P; Mas-Coma S
    Acta Trop; 2006 Nov; 100(1-2):17-23. PubMed ID: 17064656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and treatment to postoperative bile leakage: report of 38 cases.
    Zhang JM; Yu SA; Shen W; Zheng ZD
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):441-4. PubMed ID: 16109533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
    Freydière AM; Gille Y; Marcel JP; Vincent P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bacteriology of the obstructed biliary tree.
    Maddocks AC; Hilson GR; Taylor R
    Ann R Coll Surg Engl; 1973 May; 52(5):316-9. PubMed ID: 4576766
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 29. Route of infection in extrahepatic biliary tract disease. I: Experimental evidence against an entero-hepatico-biliary cycle of bacteria.
    Nielsen ML
    Scand J Gastroenterol Suppl; 1976; 37():11-6. PubMed ID: 818701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile leak following living donor liver transplantation: clinical efficacy of percutaneous transhepatic treatment.
    Kim JH; Ko GY; Sung KB; Yoon HK; Gwon DI; Kim KR; Lee SG
    Liver Transpl; 2008 Aug; 14(8):1142-9. PubMed ID: 18668647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of bile infection in patients with choledocholithiasis.
    Lygidakis NJ
    Am J Gastroenterol; 1982 Jan; 77(1):12-7. PubMed ID: 7064960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriology of hepatolithiasis.
    Tabata M; Nakayama F
    Prog Clin Biol Res; 1984; 152():163-74. PubMed ID: 6382275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of two beta-lactam antibiotics against strains of the Bacteroides fragilis group isolated from humans and from Callithrix penicillata marmosets.
    Avila-Campos MJ; de Carvalho MA; Veiga-Damasceno CA; Osório-Cisalpino E
    Rev Latinoam Microbiol; 1994; 36(3):159-62. PubMed ID: 7709091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problems of bacteriological bile duct diagnosis].
    Tauchnitz C; Storch W
    Dtsch Gesundheitsw; 1972 Nov; 27(44):2068-70. PubMed ID: 4569166
    [No Abstract]   [Full Text] [Related]  

  • 35. [Infection in biliary surgery. Per and post-operative bacteriological study (author's transl)].
    Rives J; Scavizzi M; Dropsy G; Convers G
    Chirurgie; 1978; 104(8):766-74. PubMed ID: 107009
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical and pharmacokinetic study of cefotetan in biliary tract infections: preliminary report.
    Cristiano P; Lobello R; Iovene MR; De Ascentis G; Altucci P; Paradisi F; Manguso L
    Chemioterapia; 1988 Aug; 7(4):233-6. PubMed ID: 3180302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibacterial therapy in surgery of the biliary tract (a review of the literature)].
    Ermolov AS; Ivanov VA; Udovskiĭ EE; Mironer EF
    Khirurgiia (Mosk); 1986 Feb; (2):137-42. PubMed ID: 3515030
    [No Abstract]   [Full Text] [Related]  

  • 38. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
    O'Keefe JP; Tally FP; Barza M; Gorbach SL
    Rev Infect Dis; 1979; 1(1):106-12. PubMed ID: 318211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of tolerance to cefoxitin in anaerobic bacteria.
    Goldstein EJ; Kwok YY; Sutter VL
    Antimicrob Agents Chemother; 1981 Jul; 20(1):146-8. PubMed ID: 7283412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin.
    Fraser DG
    Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.